EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus

Anna Radziszewska iD, Hannah Peckham, Restuadi Restuadi, Melissa Kartawinata, Dale Moulding, Nina M de Gruijter, George A Robinson iD, Maryam Butt, Claire T Deakin, Meredyth G Ll Wilkinson iD, Lucy R Wedderburn, Elizabeth C Jury iD und 2 weitere

Clinical and Experimental Immunology · 2025

DOI: 10.1093/cei/uxae127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Anna Radziszewska und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, GOSH, London, UK. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mitochondria, Interferon Type I, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, University College London Hospital, Centre for Adolescent Rheumatology Versus Arthritis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile systemic lupus erythematosus (JSLE) is an autoimmune condition which causes significant morbidity in children and young adults and is more severe in its presentation than adult-onset SLE. While many aspects of immune dysfunction have been studied extensively in adult-onset SLE, there is limited and contradictory evidence of how cytotoxic CD8+ T cells contribute to disease pathogenesis and studies exploring cytotoxicity in JSLE are virtually non-existent. Here, we report that CD8+ T cell cytotoxic capacity is reduced in JSLE versus healthy controls, irrespective of treatment or disease activity. Transcriptomic and serum metabolomic analysis identified that this reduction in cytotoxic CD8+ T cells in JSLE was associated with upregulated type I interferon (IFN) signalling, mitochondrial dysfunction, and metabolic disturbances when compared to controls. Greater interrogation of the influence of these pathways on altered cytotoxic CD8+ T cell function demonstrated that JSLE CD8+ T cells had enlarged mitochondria and enhanced sensitivity to IFN-α leading to selective apoptosis of effector memory (EM) CD8+ T cells, which are enriched for cytotoxic mediator-expressing cells. This process ultimately contributes to the observed reduction in CD8+ T cell cytotoxicity in JSLE, reinforcing the growing evidence that mitochondrial dysfunction is a key pathogenic factor affecting multiple immune cell populations in type I IFN-driven rheumatic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicMitochondriaInterferon Type ICD8-Positive T-LymphocytesT-Lymphocytes, CytotoxicHumansFemaleChildAdolescentMaleApoptosisImmunologic MemorySignal TransductionCytotoxicity, Immunologic

Stichwörter der Autor:innen

CD8+ T cellscytotoxicityinterferonjuvenile systemic lupus erythematosus

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, GOSH, London, UK.
  • Department of Ageing, Rheumatology & Regenerative Medicine, Division of Medicine, UCL, London, UK.
  • Infection, Immunity and Inflammation Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
  • NIHR Biomedical Research Centre at Great Ormond Street Hospital, London, UK.
  • Developmental Biology and Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.

ORCID-Profile: Anna Radziszewska, George A Robinson, Meredyth G Ll Wilkinson, Elizabeth C Jury, Elizabeth C Rosser, Coziana Ciurtin

Förderung

  • National Institute for Health and Care Research
  • University College London Hospital
  • Centre for Adolescent Rheumatology Versus Arthritis
  • University College London
  • UCL Hospital and Great Ormond Street Hospital
  • University College London Division of Medicine
  • Centre of Excellence grants from Versus Arthritis
  • Great Ormond Street Hospital Children's Charity

Zitieren

APA

Radziszewska, A., Peckham, H., Restuadi, R., Kartawinata, M., Moulding, D., de Gruijter, N. M., Robinson, G. A., Butt, M., Deakin, C. T., Wilkinson, M. G. L., Wedderburn, L. R., Jury, E. C., Rosser, E. C., & Ciurtin, C. (2025). Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae127

Vancouver

Radziszewska A, Peckham H, Restuadi R, Kartawinata M, Moulding D, de Gruijter NM, et al. Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxae127

BibTeX
@article{Radziszewska2025,
  author = {Radziszewska, Anna and Peckham, Hannah and Restuadi, Restuadi and Kartawinata, Melissa and Moulding, Dale and de Gruijter, Nina M and Robinson, George A and Butt, Maryam and Deakin, Claire T and Wilkinson, Meredyth G Ll and Wedderburn, Lucy R and Jury, Elizabeth C and Rosser, Elizabeth C and Ciurtin, Coziana},
  title = {Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  doi = {10.1093/cei/uxae127}
}
Kostenlos starten →